VASOPRESSIN
These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014
Approved
Approval ID
04e0c406-6b49-4c0b-abc5-9a1a75532485
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 31, 2023
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
VASOPRESSIN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-930
Application NumberANDA213206
Product Classification
M
Marketing Category
C73584
G
Generic Name
VASOPRESSIN
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 1, 2022
FDA Product Classification
INGREDIENTS (5)
VASOPRESSINActive
Quantity: 20 [USP'U] in 1 mL
Code: Y4907O6MFD
Classification: ACTIB
SODIUM ACETATEInactive
Code: 4550K0SC9B
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT